Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection. [electronic resource]
Producer: 20190422Description: 153-165 p. digitalISSN:- 1873-3441
- Administration, Inhalation
- Animals
- Antitubercular Agents -- administration & dosage
- Delayed-Action Preparations -- administration & dosage
- Disease Models, Animal
- Drug Carriers -- chemistry
- Drug Compounding -- methods
- Drug Liberation
- Female
- Humans
- Macrophages, Alveolar -- drug effects
- Mice
- Mice, Inbred BALB C
- Mycobacterium tuberculosis -- drug effects
- Particle Size
- Polylactic Acid-Polyglycolic Acid Copolymer -- chemistry
- Pulmonary Alveoli -- drug effects
- THP-1 Cells
- Treatment Outcome
- Tretinoin -- administration & dosage
- Tuberculosis, Pulmonary -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.